These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 4828627)
61. [Use of lithium carbonate in psychiatric therapy. Apropos of 85 cases]. Darcourt G Psychopharmacologie; 1973; 0(0):26-42. PubMed ID: 4599704 [No Abstract] [Full Text] [Related]
62. [Therapeutic drug monitoring of lithium carbonate]. Higuchi S Nihon Rinsho; 1990 Feb; 48 Suppl():1124-6. PubMed ID: 2113113 [No Abstract] [Full Text] [Related]
63. Some remarks on the influence of lithium carbonate on patients with temporal epilepsy. Jus A; Villeneuve A; Gautier J; Pires A; Côté JM; Jus K; Villeneuve R; Perron D Int J Clin Pharmacol; 1973 Feb; 7(1):67-74. PubMed ID: 4699387 [No Abstract] [Full Text] [Related]
64. Lithium carbonate. A survey of the history and current status of Lithium in treating mood disorders. Prien RF; Caffey EM; Klett CJ Dis Nerv Syst; 1971 Aug; 32(8):521-31. PubMed ID: 4937542 [No Abstract] [Full Text] [Related]
65. Effectiveness of lithium carbonate in the prevention of manic and depressive episodes. Tucker WI; Bell GO Med Clin North Am; 1972 May; 56(3):681-6. PubMed ID: 5034895 [No Abstract] [Full Text] [Related]
66. The use of balanced incomplete block designs in comparative bioavailability trails. Westlake WJ Biometrics; 1974 Jun; 30(2):319-27. PubMed ID: 4833141 [No Abstract] [Full Text] [Related]
67. Pharmacokinetics of lithium preparations in patients. Johnson GF; Hunt GE Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848 [TBL] [Abstract][Full Text] [Related]
68. Influence of lithium carbonate on patients with temporal epilepsy. Jus A; Villeneuve A; Gautier J; Pires A; Côté JM; Jus K; Villeneuve R; Perron D Can Psychiatr Assoc J; 1973 Feb; 18(1):77-8. PubMed ID: 4571309 [No Abstract] [Full Text] [Related]
69. [Practical view points on lithium therapy]. Felber W; König L Z Arztl Fortbild (Jena); 1977 Apr; 71(8):408-10. PubMed ID: 878513 [No Abstract] [Full Text] [Related]
70. Evaluation of a slow-release lithium carbonate formulation. Cooper TB; Simpson GM; Lee JH; Bergner PE Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833 [TBL] [Abstract][Full Text] [Related]
71. [Prophylactic treatment of manic-depressive psychoses with lithium carbonate. Theoretical and practical value of the study of variations of plasma concentrations]. Hakim C; Pichot P Ann Med Psychol (Paris); 1972 Feb; 1(2):238-46. PubMed ID: 5051251 [No Abstract] [Full Text] [Related]
72. Lithium carbonate and convulsive disorders. Erwin CW; Gerber CJ; Morrison SD; James JF Arch Gen Psychiatry; 1973 May; 28(5):646-8. PubMed ID: 4573418 [No Abstract] [Full Text] [Related]
73. Lithium carbonate in the ambulatory, chronically psychotic patient. Neal WL; Munden KJ J Tenn Med Assoc; 1973 Mar; 66(3):215-6. PubMed ID: 4695508 [No Abstract] [Full Text] [Related]
74. Lithium carbonate: a clinical study. Zall H; Therman PG; Myers JM Am J Psychiatry; 1968 Oct; 125(4):549-55. PubMed ID: 5711819 [No Abstract] [Full Text] [Related]
76. Sustained-release lithium tablets and renal function. Vestergaard P Br Med J; 1980 Jan; 280(6207):113. PubMed ID: 7353112 [No Abstract] [Full Text] [Related]
77. [Distribution of lithium in the brain and blood serum of mice after single and chronic administration]. Kiseleva IP; Leont'ev VG Farmakol Toksikol; 1970; 33(5):614-6. PubMed ID: 5493223 [No Abstract] [Full Text] [Related]
78. A comparison of three types of lithium release preparations. Lippmann S; Evans R Hosp Community Psychiatry; 1983 Feb; 34(2):113-4. PubMed ID: 6826160 [No Abstract] [Full Text] [Related]
79. Absorption of lithium from controlled-release preparations. Hullin RP Br Med J; 1977 May; 1(6072):1349. PubMed ID: 861616 [No Abstract] [Full Text] [Related]